Francis Giles
Hematology & Oncology · San Antonio, TXNPI 1750480950
Payments from drug & device makers
Across 35 payments — averaging $12,933 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Morphosys, US Inc.$419K
- AstraZeneca$17K
- Morphosys AG$10K
- Pfizer$7K
Across 26 payments — averaging $1036.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$26K
- Novartis$1K
What the payments were for
- Consulting fees$425,80098%
- Speaking & faculty fees$7,3402%
- Travel & lodging$2,8071%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Morphosys, US Inc. | 19 | $418,607 |
| AstraZeneca | 2 | $16,724 |
| Morphosys AG | 1 | $10,000 |
| Pfizer | 13 | $7,340 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$452,672 in reported general payments places this provider in the 80th percentile of 838 hematology & oncology providers in Texas.
Other hematology & oncology in San Antonio
- Kyriakos PapadopoulosSan Antonio$18.5M
- Drew RascoSan Antonio$14.1M
- David SommerhalderSan Antonio$10.4M
- Emmalind AponteSan Antonio$4.4M
- Manuel SantiagoSan Antonio$3.9M
- Paul ShaughnessySan Antonio$3.7M
- Ildefonso Rodriguez RiveraSan Antonio$2.7M
- Sharon WilksSan Antonio$2.5M
- Elias JabbourHouston$264.1M
- Luhua WangHouston$79.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.